BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28449664)

  • 21. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA; Bastacky SI; Myers EN; Hunt JL
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
    Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
    Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.
    Tsai WC; Sheu LF; Nieh S; Yu CP; Sun GH; Lin YF; Chen A; Jin JS
    World J Urol; 2007 Mar; 25(1):73-80. PubMed ID: 17021824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].
    Zhang W; Yu WJ; Chen YQ; Kang EH; Liu Y; Zhuang J; Jiang YX; Chu J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):692-697. PubMed ID: 27760610
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of p53 and bcl-2 proteins is not associated with sarcomatoid change in renal cell carcinoma.
    Kanamaru H; Li B; Miwa Y; Akino H; Okada K
    Urol Res; 1999 Jun; 27(3):169-73. PubMed ID: 10422817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
    Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: new diagnostic and prognostic information.
    Yu W; Zhang W; Jiang Y; Wang Y; Li Y; Wang J; Sun L; Ran W; Li H
    Acta Histochem; 2013 Jun; 115(5):452-9. PubMed ID: 23219441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
    Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
    J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
    Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.